Octave is collaborating with Quest Diagnostics to expand access to its MSDA blood test, used to measure disease activity in ...

Although this is one route for a diagnostic device, securing FDA approval allows Cleveland Diagnostics to send IsoPSA kits ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) ...

"The whole future of precision medicine for MS and Parkinson's is managing to the biology of the disease to individualize the ...

Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson's disease, today ...

In the fast-growing diagnostics testing market, Hologic HOLX and Quest Diagnostics DGX stand out as two prominent players, ...

DGX pushes growth through acquisitions and advanced diagnostics even as rising debt and tough competition pressure its outlook.

A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve ...

The study evaluated two blood-based tests developed by Quest Diagnostics. One of the tests produces a likelihood score based on results of circulating blood levels of the biomarkers amyloid beta (AB) ...

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...